Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Lumen Technologies And 3 Other Stocks Under $3 Insiders Are Buying

Published 28/02/2024, 12:21
© Reuters.  Lumen Technologies And 3 Other Stocks Under $3 Insiders Are Buying
LUMN
-
RZLT
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

The Dow Jones index closed lower by around 100 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Brightcove

  • The Trade: Brightcove Inc. (NASDAQ: BCOV) 10% owner Jonathan Brolin acquired a total of 41,747 shares an average price of $1.86. To acquire these shares, it cost around $77,667. The company’s CEO also bought 25,000 shares of the company.
  • What’s Happening: On Feb. 22, Brightcove reported fourth-quarter financial results and issued FY24 guidance below estimates..
  • What Brightcove Does: Brightcove Inc is a provider of cloud-based streaming technology and services.
Lumen Technologies
  • The Trade: Lumen Technologies, Inc. (NYSE: LUMN) Director T Michael Glenn acquired a total of 50,000 shares at at an average price of $1.47. To acquire these shares, it cost around $73,300.
  • What’s Happening: On Feb. 6, Lumen Technologies reported better-than-expected fourth-quarter financial results.
  • What Lumen Technologies Does: With 450,000 route miles of fiber, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises.
Check This Out: Macy's, Lowe's And 3 Stocks To Watch Heading Into Tuesday

Rezolute

  • The Trade: Rezolute, Inc. (NASDAQ: RZLT) Chief Medical Officer Brian Kenneth Roberts acquired a total of 8,000 shares at an average price of $1.69. The insider spent around $13,540 to buy those shares.
  • What’s Happening: On Feb. 13, Rezolute posted a narrower-than-expected second-quarter loss.
  • What Rezolute Does: Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies.
Cyanotech
  • The Trade: Cyanotech Corporation (OTC: CYAN) VP, Operations Glenn Jensen acquired a total of 16,835 shares at an average price of $0.31. The insider spent around $5,222 to buy those shares.
  • What’s Happening: On Feb. 8, Cyanotech posted a wider quarterly loss.
  • What Cyanotech Does: Cyanotech Corp is engaged in the production of natural products derived from microalgae for the nutritional supplements market.
Don’t forget to check out our premarket coverage here

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.